Ecuador's health ministry and the country's national health authority. It wrote the 2017 national cancer strategy, runs the public network that buys cancer care from SOLCA, and chairs the council that keeps the national list of essential medicines.
Under article 4 of Ecuador's Ley Orgánica de Salud the Ministerio de Salud Pública is the national health authority, responsible for applying and enforcing the law. Its Acuerdo Ministerial 0059-2017 approved the Estrategia Nacional para la Atención Integral del Cáncer en el Ecuador (dated April 2017, valid for five years) and made it binding on the whole national health system. The strategy records that the public network (Red Pública Integral de Salud, which the Constitution defines as state establishments, social security and other state providers; the strategy's list of abbreviations names three social security institutes, IESS, ISSFA for the armed forces and ISSPOL for the police) covers prevention, diagnosis and treatment, and buys services from private providers in a complementary network, among them SOLCA. The Constitution, quoted in the agreement, guarantees free specialised care at every level to people with catastrophic or highly complex illness (article 50). The coordinates are an approximate point for the Ministry's offices in south Quito.
The strategy set screening recommendations for cervical, breast, colorectal and stomach cancer and informed-choice testing for prostate cancer, and asked for histopathological diagnosis and staging within 45 days. An IAEA, WHO and IARC imPACT Review in March 2019, requested by the Ministry, recommended a cancer control steering committee and a budgeted action plan. On 15 November 2022 the Ministry presented the eleventh revision of the Cuadro Nacional de Medicamentos Básicos, which grew from 454 to 484 active ingredients and added 14 cancer and immunomodulating medicines. According to the legal publisher LEXIS and the law firm NMS, the Ley Orgánica para la Atención Integral del Cáncer, published on 4 March 2026, makes cancer a national priority and creates a National Cancer Committee attached to the health authority and a five-year National Cancer Plan; OnCo did not read the official text.
Shows the cost of the referral path between Ecuador's public network and SOLCA: women who entered through the public system started treatment about three months later, and in advanced stages this was linked to shorter survival.
A picture of the kind of cancer research Ecuador produces, mostly case reports, cross-sectional studies and reviews, and a call to raise its quality and align it with the cancers that affect most people.
The latest published rates from the Quito registry, which predates Ecuador's other population-based registries. They show thyroid cancer overtaking breast cancer in Quito's women and cervical and stomach cancer no longer falling, which the authors read as a reason to strengthen prevention.
Stomach cancer causes more cancer deaths than any other cancer in Ecuador in IARC's 2024 estimate, and this study shows high-risk clusters along the Andes.
Shares SOLCA Núcleo de Quito, Hospital Oncológico Solón Espinosa Ayala, Registro Nacional de Tumores (Quito population-based cancer registry), Gastric & gastro-oesophageal junction cancer, Cervical cancer.
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, International Agency for Research on Cancer (IARC / WHO), Gastric & gastro-oesophageal junction cancer.
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares Global oncology and access in low- and middle-income countries, Gastric & gastro-oesophageal junction cancer, Cervical cancer, Breast cancer (all types).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, International Atomic Energy Agency: Rays of Hope, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO).
Shares World Health Organization Cancer Programme, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/